Xylem
873 hedge funds and large institutions have $19.6B invested in Xylem in 2023 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 325 increasing their positions, 313 reducing their positions, and 96 closing their positions.
109% more call options, than puts
Call options by funds: $45.4M | Put options by funds: $21.7M
4% more repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 313
0.15% less ownership
Funds ownership: 88.03% → 87.88% (-0.15%)
4% less funds holding
Funds holding: 908 → 873 (-35)
18% less capital invested
Capital invested by funds: $24B → $19.6B (-$4.31B)
24% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 96
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$125M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$112M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$112M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$104M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$89.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$190M |
| 2 |
Man Group
London,
United Kingdom
|
-$158M |
| 3 |
BlackRock
New York
|
-$154M |
| 4 |
Two Sigma Investments
New York
|
-$76.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$53.9M |
XYL Hedge Fund Activity: Q3 2023 in Review
873 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q3 2023, worth a combined $19.6B — down 18% from $24B a quarter earlier.
Sellers outnumbered buyers: 96 funds closed out of XYL and 73 opened new positions — a net loss of 23 holders — while 313 trimmed existing stakes and 325 added.
The largest buyer was UBS AM, adding an estimated $125M. The largest seller was AllianceBernstein, cutting an estimated $190M.
- 873 institutional investors held Xylem (XYL) as of Q3 2023, down from 908 in Q2 2023.
- Funds reported $19.6B of Xylem stock for Q3 2023, down 18% quarter-over-quarter.
- 73 funds opened new Xylem positions in Q3 2023 and 96 closed out, a net change of -23 holders.
- The largest Xylem buyer in Q3 2023 was UBS AM, an estimated $125M added.
- The largest Xylem seller in Q3 2023 was AllianceBernstein, an estimated $190M sold.
Based on aggregated 13F filings for Q3 2023.